Company Description
WW International, Inc. engages in the provision of weight management products and services in the United States, Germany, and internationally.
It provides various nutritional, activity, behavioral, and lifestyle tools and approaches products and services.
The company also offers various digital subscription products to weight loss and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and web-based platform; and allows members to inspire and support each other by sharing their experiences with other people on weight health journeys.
In addition, it licenses its trademarks and other intellectual property in food, beverages and other weight management-relevant consumer products and services, as well as provides publishing services.
The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019.
WW International, Inc. was founded in 1963 and is headquartered in New York, New York.
Country | United States |
Founded | 1961 |
IPO Date | Nov 15, 2001 |
Industry | Personal Services |
Sector | Consumer Discretionary |
Employees | 3,700 |
CEO | Tara Comonte |
Contact Details
Address: 675 Avenue of the Americas, 6th Floor New York, New York 10010 United States | |
Phone | 212 589 2700 |
Website | corporate.ww.com |
Stock Details
Ticker Symbol | WW |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000105319 |
CUSIP Number | 98262P101 |
ISIN Number | US98262P1012 |
Employer ID | 11-6040273 |
SIC Code | 7200 |
Key Executives
Name | Position |
---|---|
Tara M. Comonte | President, Chief Executive Officer and Director |
Felicia DellaFortuna | Chief Financial Officer |
Nicole Haag | Corporate Controller and Principal Accounting Officer |
David Helderman | Director of Investor Relations |
Jacqueline Cooke | Chief Legal and Regulatory Officer and Secretary |
Tony Yen | Head of Taiwan |
Tiffany Stevenson | Chief Engagement Officer |
Donna Boyer | Chief Product Officer |
Phillip Picardi | Chief Impact Officer |
Scott Honken PharmD | Chief Commercial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 21, 2025 | 8-K | Current Report |
Feb 28, 2025 | 10-K | Annual Report |
Feb 27, 2025 | 8-K | Current Report |
Feb 3, 2025 | 8-K | Current Report |
Nov 27, 2024 | 8-K | Current Report |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 6, 2024 | 10-Q | Quarterly Report |
Nov 6, 2024 | 8-K | Current Report |